pharma news today obesity drugs glp-1 october 2025 Giants Bet on Next-Generation Treatments to Sustain Growth Obesity GLP-1 Market Size to

The NHS website is a great starting point to signpost patients to basic advice on diet and lifestyle support

doi: 10.1053/j.gastro.2015.04.043 129 ArmstrongMJGauntPAithalGPBartonDHullDParkerRet al

For patients like Sarah, this therapy can deliver substantial improvements in weight, blood sugar control, and overall quality of life

The maintenance of glutathione cycle and survivability in neurotoxin exposed cells by Sp, led us to test its plausibility in recovering the degenerative phenotypes of well-established Drosophila Parkinson mutant model park 13

This suggests curcumin is probably a neuroprotective drug for human PD patients